Keywords: fda, asks, pk, study, before, approving, erbitux

FDA asks for PK study before approving Erbitux sBLA

Article | 09 March 2009

Print This

The Food and Drug Administration says it needs to see results from a pharmacokinetics study before it can approve a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in